Tempest Therapeutics, Inc.
TPST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001544227
No open-market purchases or sales by Tempest Therapeutics, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.44M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Tempest Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +4 vs. Q3 2025
- Shares held
- 787.5K
- +201.7K (+34.4%) vs. Q3 2025
- Total value
- $2.26M
- −$3.76M (−62.5%) vs. Q3 2025
- New holders
- 6
- 3 more added
- Sold out
- 2
- 4 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TPST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $1.44M |
| Q1 2026 | 22 | $1.29M |
| Q4 2025 | 21 | $2.26M |
| Q3 2025 | 17 | $6.02M |
| Q2 2025 | 18 | $6.42M |
| Q1 2025 | 24 | $4.42M |
| Q4 2024 | 35 | $5.66M |
| Q3 2024 | 28 | $3.94M |
| Q2 2024 | 24 | $4.70M |
| Q1 2024 | 30 | $7.58M |
| Q4 2023 | 32 | $9.88M |
| Q3 2023 | 24 | $1.05M |
| Q2 2023 | 22 | $4.86M |
| Q1 2023 | 17 | $8.72M |
| Q4 2022 | 13 | $3.54M |
| Q3 2022 | 16 | $5.36M |
| Q2 2022 | 16 | $6.67M |
| Q1 2022 | 15 | $7.12M |
| Q4 2021 | 19 | $12.4M |
| Q3 2021 | 22 | $31.8M |
| Q2 2021 | 24 | $20.5M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Tempest Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Versant Venture Management, LLC | 269,772 | $774.2K | 0.51% | 00.0% | Unchanged |
| Sabby Management, LLC | 178,592 | $512.6K | 4.27% | +178,592 | New |
| Vanguard Group Inc | 162,560 | $466.5K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 44,112 | $126.6K | 0.00% | +3,088+7.5% | Added |
| BlackRock, Inc. | 39,068 | $112.1K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 33,225 | $95.4K | 0.00% | −10.0% | Reduced |
| UBS Group AG | 17,542 | $50.3K | 0.00% | +6,153+54.0% | Added |
| Northern Trust Corp | 14,053 | $40.3K | 0.00% | +14,053 | New |
| Dimensional Fund Advisors LP | 11,444 | $32.8K | 0.00% | +11,444 | New |
| DRW Securities, LLC | 10,447 | $30.0K | 0.00% | −8,381−44.5% | Reduced |
| Morgan Stanley | 2,058 | $5.91K | 0.00% | −50−2.4% | Reduced |
| Advisor Group Holdings, Inc. | 1,613 | $4.62K | 0.00% | −42−2.5% | Reduced |
| Tower Research Capital LLC (TRC) | 1,325 | $3.80K | 0.00% | +1,325 | New |
| CIBC Private Wealth Group, LLC | 1,080 | $3.10K | 0.00% | +620+134.8% | Added |
| Federation des caisses Desjardins du Quebec | 292 | $838 | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 239 | $686 | 0.00% | +239 | New |
| SBI Securities Co., Ltd. | 56 | $161 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 37 | $107 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 18 | $52 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 3 | $9 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 8 | $0 | 0.00% | +8 | New |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −5,325−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −3−100.0% | Sold out |